X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aminopyridines - pharmacology (2512) 2512
animals (2337) 2337
science & technology (1703) 1703
life sciences & biomedicine (1593) 1593
humans (1352) 1352
male (1244) 1244
rats (914) 914
female (725) 725
pharmacology & pharmacy (700) 700
4-aminopyridine (662) 662
mice (627) 627
in vitro techniques (518) 518
dose-response relationship, drug (424) 424
aminopyridines - therapeutic use (383) 383
aminopyridines - chemistry (338) 338
neurosciences & neurology (328) 328
neurosciences (320) 320
cell line, tumor (281) 281
aminopyridines - administration & dosage (260) 260
action potentials - drug effects (252) 252
tetraethylammonium compounds - pharmacology (246) 246
oncology (245) 245
rats, sprague-dawley (239) 239
benzamides - pharmacology (221) 221
time factors (215) 215
adult (209) 209
rats, inbred strains (207) 207
structure-activity relationship (207) 207
biochemistry & molecular biology (206) 206
membrane potentials - drug effects (205) 205
guinea pigs (204) 204
indoles - pharmacology (204) 204
research article (200) 200
aminopyridines - chemical synthesis (199) 199
aminopyridines - pharmacokinetics (192) 192
middle aged (190) 190
piperazines - pharmacology (186) 186
aminopyridines (185) 185
disease models, animal (175) 175
aminopyridines - metabolism (172) 172
amrinone (171) 171
antineoplastic agents - pharmacology (169) 169
chemistry (165) 165
research (164) 164
cell proliferation - drug effects (162) 162
cells, cultured (162) 162
mutation (162) 162
aminopyridines - adverse effects (161) 161
cyclopropanes - pharmacology (157) 157
tetraethylammonium (157) 157
calcium - metabolism (156) 156
electric stimulation (156) 156
protein kinase inhibitors - pharmacology (156) 156
kinetics (154) 154
pyridines - pharmacology (153) 153
cell biology (149) 149
administration, oral (148) 148
physical sciences (148) 148
cell line (145) 145
potassium - metabolism (144) 144
analysis (140) 140
ion channels - drug effects (139) 139
mice, inbred c57bl (138) 138
rats, wistar (138) 138
apoptosis - drug effects (135) 135
cancer (135) 135
serotonin antagonists - pharmacology (135) 135
dogs (131) 131
kinases (130) 130
signal transduction - drug effects (130) 130
aged (129) 129
chemistry, medicinal (129) 129
roflumilast (122) 122
muscle contraction - drug effects (120) 120
benzamides - therapeutic use (119) 119
abridged index medicus (118) 118
morpholines - pharmacology (117) 117
models, molecular (116) 116
synaptic transmission - drug effects (116) 116
calcium - pharmacology (114) 114
xenograft model antitumor assays (114) 114
4-aminopyridine - pharmacology (113) 113
drug interactions (112) 112
4‐aminopyridine (110) 110
neurons - drug effects (110) 110
rabbits (109) 109
phosphorylation (108) 108
cardiotonic agents - pharmacology (106) 106
myocardial contraction - drug effects (106) 106
drug synergism (103) 103
signal transduction (103) 103
tetrodotoxin - pharmacology (102) 102
proteins (101) 101
science & technology - other topics (101) 101
apoptosis (100) 100
4-aminopyridine - analogs & derivatives (99) 99
multidisciplinary sciences (99) 99
molecular structure (98) 98
cyclopropanes - therapeutic use (97) 97
physiology (97) 97
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3262) 3262
Japanese (61) 61
German (49) 49
Russian (24) 24
Chinese (14) 14
French (11) 11
Spanish (9) 9
Italian (6) 6
Lithuanian (2) 2
Portuguese (2) 2
Bulgarian (1) 1
Czech (1) 1
Dutch (1) 1
Hungarian (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 06/2008, Volume 134, Issue 7, pp. 2004 - 2013
Background & Aims: Chemotherapy with an anticancer agent generally causes gastrointestinal tract disorders such as vomiting and anorexia, but the mechanism... 
Gastroenterology and Hepatology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Receptor, Serotonin, 5-HT2B - metabolism | Receptor, Serotonin, 5-HT2C - metabolism | Body Weight - drug effects | Drugs, Chinese Herbal - pharmacology | Male | Stomach - metabolism | Drugs, Chinese Herbal - metabolism | Anorexia - physiopathology | Quinolines - pharmacology | Serotonin Receptor Agonists - pharmacology | Dose-Response Relationship, Drug | Serotonin 5-HT2 Receptor Antagonists | Chalcones - pharmacology | Dopamine Antagonists - metabolism | Receptors, Ghrelin - metabolism | Indoles - pharmacology | Stomach - innervation | Stomach - drug effects | Drugs, Chinese Herbal - therapeutic use | Flavones - pharmacology | Acylation | Disease Models, Animal | Antineoplastic Agents | Rats | Thiophenes - pharmacology | Anorexia - metabolism | Dopamine Antagonists - therapeutic use | Receptors, Ghrelin - drug effects | Piperazines - pharmacology | Rats, Sprague-Dawley | Vagotomy | Cisplatin | Ghrelin - metabolism | Eating - drug effects | Gastrointestinal Agents - pharmacology | Ghrelin - blood | Animals | Dopamine Antagonists - pharmacology | Aminopyridines - pharmacology | Serotonin - metabolism | Gastrointestinal Agents - therapeutic use | Anorexia - prevention & control | Hesperidin - pharmacology | Protein Binding | Anorexia - chemically induced | Oligopeptides - pharmacology | Gastrointestinal Agents - metabolism | Medicine, Botanic | Medicine, Herbal | Index Medicus | Abridged Index Medicus
Journal Article
Investigational new drugs, ISSN 1573-0646, 06/2014, Volume 32, Issue 5, pp. 825 - 837
The G1 restriction point is critical for regulating the cell cycle and is controlled by the Rb pathway (CDK4/6-cyclin D1-Rb-p16/ink4a). This pathway is... 
Medicine & Public Health | Cell cycle | Oncology | In vivo antitumor activity | Pharmacology/Toxicology | Combination therapy | LY2835219 | Kinase inhibitor | CDK4/6 inhibitor | Cdk4/6 inhibitor | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Neoplasms - metabolism | Humans | Deoxycytidine - pharmacology | Antineoplastic Agents - therapeutic use | Deoxycytidine - therapeutic use | Aminopyridines - therapeutic use | Female | Antineoplastic Agents - pharmacology | Phosphorylation - drug effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Retinoblastoma Protein - metabolism | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Tumor Burden - drug effects | Protein Kinase Inhibitors - therapeutic use | Aminopyridines - pharmacology | Retinoblastoma Protein - antagonists & inhibitors | Cell Line, Tumor | Benzimidazoles - pharmacology | Mice | Protein Kinase Inhibitors - pharmacology | G1 Phase Cell Cycle Checkpoints - drug effects | Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Dosage and administration | Research | Gemcitabine | Studies | Protein expression | Inhibitor drugs | Kinases | Cancer therapies | Analysis | Index Medicus | CDK4 | Preclinical Studies | 6 inhibitor
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 10/2011, Volume 55, Issue 10, pp. 4652 - 4658
Journal Article
Pulmonary Pharmacology & Therapeutics, ISSN 1094-5539, 2010, Volume 23, Issue 4, pp. 235 - 256
Journal Article
Nature communications, ISSN 2041-1723, 12/2014, Volume 5, Issue 1, pp. 5712 - 5712
Increased expression of the Microphthalmia-associated transcription factor (MITF) contributes to melanoma progression and resistance to BRAF pathway... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Prognosis | Skin Neoplasms - drug therapy | Humans | Gene Expression Regulation, Neoplastic | Extracellular Signal-Regulated MAP Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - genetics | Melanoma - genetics | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Indoles - pharmacology | Pyrimidinones - pharmacology | Antineoplastic Agents - pharmacology | Benzamides - pharmacology | Proto-Oncogene Proteins B-raf - metabolism | Melanoma - metabolism | Proto-Oncogene Proteins - metabolism | Skin Neoplasms - pathology | Proto-Oncogene Proteins - antagonists & inhibitors | Microphthalmia-Associated Transcription Factor - metabolism | Signal Transduction | Proto-Oncogene Proteins - genetics | Imidazoles - pharmacology | Melanoma - pathology | Pyrimidines - pharmacology | Receptor Protein-Tyrosine Kinases - metabolism | Sulfonamides - pharmacology | Imatinib Mesylate | Piperazines - pharmacology | Skin Neoplasms - metabolism | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Animals | Receptor Protein-Tyrosine Kinases - genetics | Proto-Oncogene Proteins B-raf - genetics | Aminopyridines - pharmacology | Melanoma - drug therapy | Skin Neoplasms - genetics | Cell Line, Tumor | Oximes - pharmacology | Mice | Protein Kinase Inhibitors - pharmacology | Microphthalmia-Associated Transcription Factor - genetics | Pyridones - pharmacology | Index Medicus
Journal Article
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 01/2012, Volume 302, Issue 1, pp. 120 - 132
Journal Article